AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05308017 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Karl Storz 28F Laser Scope
Description: 28 F Laser with HoLEP
Study NCT05898308 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RiTUXimab Injection
Description: Patients assigned to the personalized maintenance treatment will be treated by additional RITUXIMAB injection depending on anti-Dsg Abs levels.
Study NCT06257667 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Respiratory Support
Description: Treatment with High Flow Nasal Cannula
Study NCT06257667 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Respiratory Support
Description: Treatment with High Flow Nasal Cannula
Study NCT04331340 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pharmacist review of LUTS
Description: Pharmacist review and recommendations, including education, behaviour, lifestyle, or medications
Study NCT04331340 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Pharmacist Provision of healthy aging leaflets
Description: Pharmacist will inquire about presence of LUTS and provide patient with healthy aging leaflets
Study NCT06794320 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: NF Protocol
Description: The daily practice of physicians in evaluating and treating patients with sNF.
Study NCT06794320 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: ASTERIC protocol
Description: i. Risk-assessment tools
Study NCT06794320 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: ASTERIC protocol
Description: ii. Fast track absolute neutrophil counts turnaround service
Study NCT06482203 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Trunk Extensor Endurance training & Scapular mobilization
Description: Trunk Extensor Endurance Training Level 1:Prone shoulder extension or prone shoulder raises Level 2: Prone back extension Level 3: Prone Ys or Y raises Level 4:Super man pose Level 5:Super man or prone cobra~(The given position should be hold for 10 seconds and performs 25 repetitions with 3 sec rests in between the efforts)~Scapular Mobilization:~Intervention program includes, supero-inferior, medio-lateral along with circumduction movements).~3 sets of 10-15 repetitions of each of the supero-inferior ,medio-lateral, and circumduction movements Between each session, there was a10 or 30-second break. The length of rests was adjusted depending on the patient's endurance
Study NCT05307705 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LOXO-783
Description: Oral
Study NCT05307705 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fulvestrant
Description: Intramuscular
Study NCT06794320 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: ASTERIC Protocol
Description: iii. A decision tool for patient management and initial antibiotic use
Study NCT05307705 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Imlunestrant
Description: Oral
Study NCT06794320 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: ASTERIC Protocol
Description: iv. A decision tool for patient management and subsequent antibiotic use
Study NCT06794320 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: ASTERIC Protocol
Description: v. An educational package
Study NCT06794320 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: ASTERIC Protocol
Description: vi. A decision tool for patient disposal - discharge or emergency department ward observation
Study NCT04937491 — intervention group
Intervention type: DEVICE
Intervention: New medical device (ReBalans)
Description: Body worn, battery powered bioimpedance measuring patch device.
Study NCT05307705 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Abemaciclib
Description: Oral
Study NCT05307705 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Anastrozole, Exemestane, or Letrozole
Description: Oral
Study NCT06793501 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Reablement intervention
Description: Reablement's implementation in this study is characterized by a comprehensive assessment of the older person's everyday activities, both current and past. This is done through a person-centered interview using the Canadian Occupational Performance Measure (COPM). The COPM is based on the assumptions described in the theoretical framework of CMOP-E. Based on the assessment, the older adult selects a personal activity goal, which consists of an activity they consider meaningful and wish to improve. In collaboration with the older adult and staff, a goal-oriented support plan, also referred to as a training program, is developed to achieve the goal. Nursing assistant staff support the older persons in performing defined training activities and receive supervision from rehabilitation staff. The support plan and progress toward the activity goal are evaluated through regular reassessments during a fixed intervention period of eight weeks.
Study NCT06793501 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Control group
Description: TAU includes a general approach where all activities that the older adult engages in during everyday life are considered rehabilitative. The staff are encouraged to motivate the older adult to do as much as possible independently, in order to prevent loss of function and maintain the ability to perform activities. The approach does not involve any direction toward specific activities where there is a rehabilitative need. It does not include any formulated goals or follow-up. Additionally, there is no specific education offered to the nursing assistants on how to encourage the older adult or how to follow-up up on the extent to which the approach is applied.
Study NCT06796504 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Procedure/Surgery: Implant Procedure
Description: The SetPoint System (study device)contains a miniaturized stimulator (implnat) that is surgically implanted inside the left side of the neck on the vagus nerve (implant procedure). All eligible subjects will undergo the surgery under general anesthesia in outpatient settings.
Study NCT06796504 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Procedure/Surgery: Implant Procedure
Description: The SetPoint System (study device)contains a miniaturized stimulator (implnat) that is surgically implanted inside the left side of the neck on the vagus nerve (implant procedure). All eligible subjects will undergo the surgery under general anesthesia in outpatient settings.
Study NCT06796504 — intervention group
Intervention type: DRUG
Group type: SHAM_COMPARATOR
Intervention: Disease-Modifying Therapies (DMTs)
Description: All subjects will continue treatment with standard of care disease-modifying therapies for he duration of the study.
Study NCT06796504 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Disease-Modifying Therapies (DMTs)
Description: All subjects will continue treatment with standard of care disease-modifying therapies for he duration of the study.
Study NCT05144984 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NNC0480-0389
Description: A weekly dose of NNC0480-0389, dose increased in each cohort. The study will last for about 41weeks.
Study NCT05144984 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Semaglutide
Description: A weekly dose of semaglutide, same dose in each cohort. The study will last for about 41weeks.
Study NCT05144984 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo (NNC080-0389)
Description: A weekly dose of placebo (NNC0480-0389). The study will last for about 41weeks.
Study NCT05144984 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo (NNC080-0389)
Description: A weekly dose of placebo (NNC0480-0389). The study will last for about 41weeks.
Study NCT05144984 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo (semaglutide)
Description: A weekly dose of placebo (semaglutide). The study will last for about 41weeks.
Study NCT05144984 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo (semaglutide)
Description: A weekly dose of placebo (semaglutide). The study will last for about 41weeks.
Study NCT05307705 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paclitaxel
Description: Intravenous
Study NCT05173987 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: pembrolizumab
Description: Intravenous (IV) infusion
Study NCT05173987 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: carboplatin
Description: IV infusion
Study NCT05173987 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: paclitaxel
Description: IV infusion
Study NCT05173987 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: docetaxel
Description: IV infusion
Study NCT03721783 — intervention group
Intervention type: PROCEDURE
Intervention: Cryoablation
Description: Image guided cryoablation therapy of soft tissue lesions
Study NCT04771520 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Avapritinib
Description: Given PO
Study NCT05963204 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: ACTIVE_COMPARATOR
Intervention: Sculptra and Alastin Restorative Skin Complex
Description: Biostimulator and cosmetics
Study NCT05963204 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: ACTIVE_COMPARATOR
Intervention: Sculptra and CeraVe Daily Moisturizing Lotion
Description: Biostimulator and cosmetics
Study NCT05207033 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Regulated ad condition
Description: This intervention will determine if restriction of appealing features in e-cigarette ads deter young adults from trying the product.
Study NCT05207033 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Unregulated ad condition
Description: This intervention will determine if unrestricted appealing features in e-cigarette ads deter young adults from trying the product.
Study NCT06194604 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Instrument-assisted soft tissue mobilization
Description: Instrumented soft tissue mobilization is a type of manual therapy method.Istrumented soft tissue mobilization aims to reduce fascial limitations by increasing circulation. Increases in localized blood flow and soft tissue realignment promote muscle function, increased normal joint movement, and decreased pain.
Study NCT06194604 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Routine rehabilitation programe
Description: Routine rehabilitation programe consisting of stretching and strengthening exercises will be applied.
Study NCT06194604 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Routine rehabilitation programe
Description: Routine rehabilitation programe consisting of stretching and strengthening exercises will be applied.
Study NCT06389721 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Electroencephalogram (EEG)
Description: Measure the electrical activity of your brain before you receive chemotherapy treatment and once monthly for a maximum of 6 measurements.
Study NCT05927428 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: BRM424 Ophthalmic Solution - Dose1
Description: A topical drop of BRM424 ophthalmic solution.
Study NCT05927428 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: BRM424 Ophthalmic Solution - Dose2
Description: A topical drop of BRM424 ophthalmic solution.
Study NCT05704257 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: fetoscopy
Description: The fetoscopic arm is described above. All patients will have a laparotomy, exteriorization of the uterus, and a fetoscopic repair of the gastroschisis.
Study NCT06796504 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Device: Active stimulation
Description: Active stimulation for 1 minute once per day
Study NCT06796504 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Device: Non-active stimulation
Description: Non-active stimulation for 1 minute once per day
Study NCT06797804 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Information Technology-Assisted Horticultural Therapy Program
Description: The intervention involves technology-assisted horticultural therapy sessions conducted once a week, lasting 120 minutes per session, over a total period of 8 weeks
Study NCT05926102 — intervention group
Intervention type: GENETIC
Group type: EXPERIMENTAL
Intervention: Precision screening intervention
Description: The precision screening intervention will consist of an interpreted prostate cancer genetic risk assessment (GRA) report, provided to the participant along with tailored prostate cancer screening recommendations and, in cases of high genetic risk, genetic counseling. The risk report and supporting educational materials will also be provided to the participant's primary care provider. Usual care in this study includes receipt of a brief brochure about shared decision-making in prostate cancer screening.
Study NCT05926102 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Usual care
Description: Usual care in this study includes receipt of a brief brochure about shared decision-making in prostate cancer screening.
Study NCT05971810 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: immunonutrition supplement of ORAL IMPACT™
Description: For intervention group, patients will take immunonutrition supplement after recruitment until the day before surgery.
Study NCT05971810 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: oral chlorhexidine decontamination
Description: For intervention group, patients will use 0.12% chlorhexidine for oral rinse twice daily from the day before surgery until 3 days after surgery.
Study NCT06410820 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Procedure/Surgery: Ultrasound method group
Description: In the operating room, all of the patients will receive standard monitoring. Scans will be made in logiditunal parasagittal and transverse midline views with ultrasound. Needle entry sites in the L2-L3 and L3-L4 intervals will be determined as the intersection of the longiditunal and transverse lines.~When the spinal puncture operator is outside the room, Needle entry sites were marked for both groups.After skin marking, the pregnant woman will be asked to remain still and a subarachnoid puncture will be performed immediately. Spinal anesthesia will be administered with injection of intrathecal bupivacaine.
Study NCT05793255 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Social Phone Calls
Description: Following the collection of baseline data, the study participant will be randomly assigned to a student volunteer to begin the social phone calls. The first phone call will be scheduled to occur within one week of the consent and baseline assessments. A minimum of one social phone call will occur each week for 6weeks. Each phone call is expected to last around 1 hour with flexibility to be shorter or longer. The calls will be unstructured and designed simply to engage in conversation with the participant. The length of the phone calls, days and times will be recorded by the volunteer along with a short journal entry describing the conversation topics and any information that stood out to the volunteer. If the stroke survivor and student volunteer wish to speak more than the designated one call a week, that will be allowed if both parties agree. The same student volunteer will conduct all six sessions
Study NCT06795555 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Virtual reality food exposure
Description: Patients in this condition are exposed to a virtual kitchen environment once/day, for 5 consecutive days (from Monday, day 1, to Friday, day 5). Each session lasts 5 minutes. The VR environment was specifically developed by the study team (Natali et al, 2024) and it consists of a kitchen with foods of different calorie contents. Patients are invited to explore the environment; they can freely move, open the cupboards and the fridge, and grab and hold the foods. Participants can choose to interact with one of three versions of the virtual kitchen environment: a) a kitchen alone, b) a kitchen with a virtual pet which participants can interact with (and aimed at inducing positive mood) and c) a kitchen with a compassionate avatar which motivates the participant to face food-related fears.
Study NCT06410820 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Landmark method group
Description: In the Landmark group, the injection site will be determined using the traditional method of palpating the posterior superior iliac spine.When the spinal puncture operator is outside the room, Needle entry sites were marked for both groups.After skin marking, the pregnant woman will be asked to remain still and a subarachnoid puncture will be performed immediately. Spinal anesthesia will be administered with injection of intrathecal bupivacaine.
Study NCT04978740 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Ophthalmological examination
Description: Eye examination :~Ocular tonometry to determine intraocular pressure Refraction assessment Retina examination Slit lamp examination Visual acuity Schirmer's test Corneal topography Funduscopic examination Optical coherence tomography
Study NCT06227845 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Fecal microbiota transplant
Description: 0.1-0.3 ml liquid containing 3.5 mg/ml of maternal fecal content, (0.35mg/kg)
Study NCT05577260 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: magnesuim sulphate
Description: magnesuim sulphate
Study NCT05577260 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Description: Dexmedetomidine
Study NCT05577260 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: isobaric bupivacaine
Description: 20ml isobaric bupivacaine 0.25%
Study NCT05173987 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: cisplatin
Description: IV infusion
Study NCT05907603 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RD13-02 cell infusion
Description: CAR-T cells
Study NCT06795555 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Virtual Reality Nature Exposure
Description: Patients in this condition complete a session of VR exposure to a natural scenario (from the NatureTreksVR app) for 5 consecutive days (from Monday to Friday), one session/day. Each session lasts 5 minutes. Participants can choose exposure to one of three different natural environments, at the start of each session: a white sand beach (Blue Ocean), a snowy mountain (White Winter), or a forest in autumn foliage (Red Fall).
Study NCT06794450 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sugammadex 1 mg/kg
Description: Patient in experimental arms will receive i.v. sugammadex 1 mg/kg at the end of operating procedure from the point at which a Train-of-Four Count (TOFC) of 2 is observed
Study NCT06794450 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Neostigmine + Atropine
Description: Patient in active comparators arms will receive i.v. neostigmine 60 mcg/kg along with 0.4 mg of atropine sulfate per 1 mg of neostigmine at the end of operating procedure from the point at which a Train-of-Four Count (TOFC) of 2 is observed
Study NCT06796023 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Stretching and strengthening exercises for back muscles
Description: Stretching and strengthening exercises for back muscles
Study NCT06796023 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Stretching and strengthening exercises for back muscles
Description: Stretching and strengthening exercises for back muscles
Study NCT06796023 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Lumbar stabilization Exercises
Description: Lumbar stabilization Exercises
Study NCT06796023 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Lumbar Manipulation
Description: Lumbar Manipulation
Study NCT06793150 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Remifentanil
Description: A comparison will be made by maintaining one group with remifentanil and the other with dexmedetomidine.
Study NCT06793150 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: dexmedetomidin
Description: A comparison will be made by maintaining one group with remifentanil and the other with dexmedetomidine.
Study NCT06794814 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: oral exercise
Description: The oral exercise protocol included several physical components, namely neck and shoulder stretching, cheek puffing exercises, tongue exercises, salivary gland massage, and oral diadochokinesis.
Study NCT06795581 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: 18F-PF-06445974
Description: Injected IV followed by PET scanning
Study NCT06795295 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Implant retained mandibular overdenture
Description: Participants received dental implants to retain mandibular overdentures.
Study NCT06796855 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Selective Bladder Denervation via Radiofrequency Ablation
Description: Participants in this arm will undergo a single session of selective bladder denervation using radiofrequency ablation (RFA). The procedure is performed under general anesthesia using the Apro Korea AK-F200 system, which delivers radiofrequency energy at four submucosal points in the bladder trigone area. The energy is applied at 25 watts per site for 60 seconds, targeting nerve pathways involved in overactive bladder symptoms. The procedure is conducted using a 19F rigid cystoscope in lithotomy position, ensuring precise electrode placement. Patients are discharged on postoperative day 1 following urinary ultrasound and post-void residual (PVR) assessment. Follow-up visits are scheduled at 2, 4, and 12 weeks to evaluate symptom improvement and safety.